Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Meiji

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Meiji's Japan sales performance.

Envision Pharma Group relocates to support growth

Envision Pharma Group relocates to support growth The agency now has 14 offices, five of which are based in the UK, six are in the US, and a further three in Serbia, Australia and Japan.

Daily Brief: Orchard raises $150m, Astellas swoops for early-stage gene company, Amicus gets FDA Fabry approval

Daily Brief: Orchard raises $150m, Astellas swoops for early-stage gene company, Amicus gets FDA Fabry approval Astellas acquires UK gene therapy company Quethera. Japan’s Astellas Pharma is to acquire UK-based gene therapy company Quethera for $85m. ... The drug is already approved in other major markets, including Europe, Japan, Australia and Canada.

FDA clears Kyowa Kirin’s skin lymphoma therapy Poteligeo

FDA clears Kyowa Kirin’s skin lymphoma therapy Poteligeo Kyowa Kirin has been selling Poteligeo in Japan since 2012, and the company says its approval in the US is a key milestone on the path to becoming a  global specialty ... Sales of Poteligeo in Japan were 1.9bn yen ($17m) in fiscal 2017, and are

New cancer drugs can’t quite plug the revenue hole at AZ

New cancer drugs can’t quite plug the revenue hole at AZ Overall sales fell 5% to $10.33bn, however, thanks to generic competition taking another chunk out of cholesterol drug Crestor (rosuvastatin) sales, particularly in Europe and Japan. ... its launch in Japan, while Tagrisso grew 82% to $760m on the back

Happy 70th birthday NHS: the next 70 need to be very different

Happy 70th birthday NHS: the next 70 need to be very different This still leaves it in line with an unweighted EU-15 average of 9.8% of national income, but far behind countries such as the US (16.9%), Japan (11.2%),

[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics